Study finds Botox cuts pediatric chronic migraine headaches

A prospective survey led by researchers astatine Children's National recovered that onabotulinumtoxinA (ONA), commonly known arsenic Botox, reduces headache frequence and headache-related disablement successful children and young adults with chronic migraine, providing important grounds to enactment its usage successful a pediatric colonisation wherever attraction options stay limited.